Filana Therapeutics, Inc. Prepaid Expense and Other Assets, Current
Filana Therapeutics, Inc. (FLNA) had Prepaid Expense and Other Assets, Current of $1.39 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › and Other Assets
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-05-07
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.39M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $2.21M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $2.83M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $2.44M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.39M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.21M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $2.83M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.44M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.82M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $7.96M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $13.57M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $14.83M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $9.83M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $8.50M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $7.83M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $8.50M 10-Q · filed 2024-08-08 | $6.09M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $7.53M 10-Q · filed 2023-05-01 | |
| 2022-12-31 | $10.21M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $8.61M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $6.97M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $12.51M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $11.04M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $10.39M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.30M 10-Q · filed 2021-08-04 | |
| 2020-12-31 | $488.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $997.00K 10-Q · filed 2020-11-09 | |
| 2019-12-31 | $268.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |